Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | retinoid X receptor, alpha | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | retinoic acid receptor rxr beta a | Get druggable targets OG5_130073 | All targets in OG5_130073 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | Get druggable targets OG5_130073 | All targets in OG5_130073 |
Schistosoma japonicum | ko:K08524 nuclear receptor, subfamily 2, group B, member 1, putative | Get druggable targets OG5_130073 | All targets in OG5_130073 |
Schistosoma mansoni | retinoic acid receptor RXR | Get druggable targets OG5_130073 | All targets in OG5_130073 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | ecdysteroid receptor | retinoid X receptor, alpha | 435 aa | 352 aa | 23.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | doublecortin family protein | 0.0021 | 0.0089 | 1 |
Schistosoma mansoni | rab6-interacting | 0.0021 | 0.0089 | 0.0089 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0128 | 0.7216 | 0.7216 |
Schistosoma mansoni | polycystin 1-related | 0.0021 | 0.0089 | 0.0089 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.0021 | 0.0089 | 0.0089 |
Brugia malayi | hypothetical protein | 0.0021 | 0.0089 | 1 |
Echinococcus granulosus | RUN | 0.0021 | 0.0089 | 0.0089 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.002 | 0 | 0.5 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.0021 | 0.0089 | 1 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0128 | 0.7182 | 0.7182 |
Onchocerca volvulus | 0.0021 | 0.0089 | 0.5 | |
Brugia malayi | Doublecortin family protein | 0.0021 | 0.0089 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0021 | 0.0089 | 0.0089 |
Toxoplasma gondii | exonuclease III APE | 0.002 | 0 | 0.5 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0128 | 0.7216 | 0.7216 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0 | 0.5 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0128 | 0.7182 | 0.7182 |
Schistosoma mansoni | lipoxygenase | 0.0089 | 0.4619 | 0.4619 |
Schistosoma mansoni | hypothetical protein | 0.017 | 1 | 1 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0021 | 0.0089 | 0.0089 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.002 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0089 | 1 |
Onchocerca volvulus | 0.0021 | 0.0089 | 0.5 | |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.002 | 0 | 0.5 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.0021 | 0.0089 | 0.0089 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.002 | 0 | 0.5 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | 0.0123 | 0.6893 | 0.6893 |
Echinococcus multilocularis | geminin | 0.017 | 1 | 1 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.002 | 0 | 0.5 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0021 | 0.0089 | 0.0089 |
Schistosoma mansoni | hypothetical protein | 0.017 | 1 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0 | 0.5 |
Echinococcus multilocularis | RUN | 0.0021 | 0.0089 | 0.0089 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0089 | 1 |
Brugia malayi | hypothetical protein | 0.0021 | 0.0089 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.002 | 0 | 0.5 |
Schistosoma mansoni | loxhd1 | 0.0021 | 0.0089 | 0.0089 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.002 | 0 | 0.5 |
Schistosoma mansoni | rab6-interacting | 0.0021 | 0.0089 | 0.0089 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0021 | 0.0089 | 0.0089 |
Schistosoma mansoni | lipoxygenase | 0.0128 | 0.7182 | 0.7182 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0021 | 0.0089 | 0.0089 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0 | 0.5 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.002 | 0 | 0.5 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0021 | 0.0089 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Transactivation of RARalpha in human COS7 cells at 10 uM by luciferase reporter gene assay | ChEMBL. | 20656484 | |
Activity (binding) | Transactivation of PPARgamma | ChEMBL. | 20656484 | |
Activity (binding) | = 40 % | Transactivation of PPARgamma/RXRalpha heterodimer | ChEMBL. | 20656484 |
EC50 (functional) | = 205 nM | Agonist activity at RXRalpha by luciferase reporter gene assay | ChEMBL. | 20656484 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.